Top compounds associated with response to LEMD2


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.081 0.03
mRNA cimetidine CTRPv2 pan-cancer AAC 0.14 0.03
mRNA CP724714 GDSC1000 pan-cancer AAC 0.071 0.03
mRNA XMD13-2 GDSC1000 pan-cancer AAC 0.066 0.03
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.083 0.03
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.04
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.04
mRNA TKI258 CCLE pan-cancer AAC -0.097 0.04
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.06 0.04
mRNA clofarabine CTRPv2 pan-cancer AAC -0.061 0.04
Download CSV